
Viz.ai Receives First and Only FDA 510(k) Clearance for Subdural Measurements
New AI algorithm enables precise and reliable labeling, visualization and quantification of subdural hemorrhage to make accurate and timely treatment...
Jun 12, 2025
Explore our News & Press
New AI algorithm enables precise and reliable labeling, visualization and quantification of subdural hemorrhage to make accurate and timely treatment...
Jun 12, 2025
Real-world data highlights how Viz.ai accelerates access to ICH treatment SAN FRANCISCO – June 9, 2025 - Viz.ai, the leader...
Jun 09, 2025
Multi-year collaboration with Novartis to develop AI-powered workflows for prostate and breast cancer, helping to reach patients eligible to benefit...
Jun 02, 2025
Comprehensive suite of solutions designed to empower oncology care teams, accelerating patient diagnosis and treatment Viz.ai’s strategic expansion into new...
May 28, 2025
Companies will collaborate on an AI-powered care improvement solution for patients with high-risk COPD SAN FRANCISCO – May 20, 2025...
May 20, 2025
New feature provides AI-enhanced 3D imaging to improve neurovascular visualization and streamline workflows SAN FRANCISCO – April 30, 2025 -...
Apr 30, 2025
Real-world evidence supports Viz ICH Plus for reliable volume and midline shift estimation SAN FRANCISCO – April 23, 2025 –...
Apr 23, 2025
Honored for excellence and innovation in cardiovascular health diagnostics for Viz HCM module SAN FRANCISCO – April 4, 2025 –...
Apr 04, 2025
Real-world evidence to be presented at the American College of Cardiology Scientific Session 2025 demonstrates positive impact of Viz.ai on...
Mar 26, 2025